MoneyWorks4Me

Dr. Reddy's Laboratories’ consolidated net profit drops 69% in Q1

23 Jul 2026 Evaluate

Dr. Reddy's Laboratories has reported its results for the first quarter ended June 30, 2026 (Q1FY27).

The company has reported an 86.33% decline in its standalone net profit at Rs 404.70 crore for the quarter ended June 30, 2026, as compared to Rs 2,961.20 crore for the same quarter in the previous year. Total income declined by 32.05% to Rs 5,577.00 crore for Q1FY27 as compared to Rs 8,207.80 crore for the corresponding quarter of the previous year.

On a consolidated basis, the company has reported a 68.67% decline in its net profit at Rs 444.30 crore for Q1FY27, as compared to Rs 1,418.10 crore for the same quarter in the previous year. Total income declined by 4.60% to Rs 8,454.50 crore for Q1FY27 as compared to Rs 8,862.40 crore for the corresponding quarter of the previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..